Literature DB >> 22219307

Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.

E R Martins1, J Melo-Cristino, M Ramirez.   

Abstract

The population of group B streptococci (GBS) associated with invasive infections in nonpregnant adults from 2001 to 2008 was analyzed in isolates submitted from 24 hospital laboratories in Portugal (n = 225). The isolates were characterized by antimicrobial susceptibility, pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and surface protein gene profiling. GBS invasive cases were found more frequently among men in all age groups. In addition, serotype Ia was the most frequent in our collection, whereas serotype V is dominant elsewhere. Serotype Ia was represented mainly by a single PFGE cluster defined by sequence type 23 (ST23) and surface protein gene eps and by ST24 and bca, similarly to neonatal invasive infections in Portugal, indicating that the same genetic lineages can be responsible for both vaginal colonization and invasive disease in all age groups. In contrast, the hypervirulent serotype III/ST17 neonatal lineage was responsible for a minority of infections. Serotype V isolates were distributed into two genetic lineages, one defined by ST1 and surface protein gene alp3 and macrolide resistant, and another presenting with ST2 and eps and fully susceptible to all antimicrobials tested. The erm(TR) gene was the most frequently found among erythromycin-resistant isolates, while the bovine-associated tet(O) gene was found in a minority of tetracycline-resistant isolates. Our data emphasize the importance of local identification of the genetic lineages responsible for GBS invasive infections in nonpregnant adults. The dominance of serotype Ia in invasive disease in Portugal highlights the importance of this serotype in GBS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219307      PMCID: PMC3318525          DOI: 10.1128/JCM.05488-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  57 in total

1.  Genetic characterization and diversity of Streptococcus agalactiae isolates with macrolide resistance.

Authors:  Monika Brzychczy-Włoch; Tomasz Gosiewski; Małgorzata Bodaszewska; Wojciech Pabian; Małgorzata Bulanda; Piotr Kochan; Magdalena Strus; Piotr B Heczko
Journal:  J Med Microbiol       Date:  2010-03-25       Impact factor: 2.472

2.  Identification of surface proteins of group B streptococci: serotyping versus genotyping.

Authors:  Andreas Radtke; Fanrong Kong; Kåre Bergh; Randi Valsø Lyng; Danny Ko; Gwendolyn L Gilbert
Journal:  J Microbiol Methods       Date:  2009-06-30       Impact factor: 2.363

3.  Evidence for rare capsular switching in Streptococcus agalactiae.

Authors:  Elisabete Raquel Martins; José Melo-Cristino; Mário Ramirez
Journal:  J Bacteriol       Date:  2009-12-18       Impact factor: 3.490

4.  Invasive group B streptococcus (GBS) disease in Norway 1996-2006.

Authors:  H Bergseng; M Rygg; L Bevanger; K Bergh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-17       Impact factor: 3.267

5.  Characterisation of invasive group B streptococci based on investigation of surface proteins and genes encoding surface proteins.

Authors:  E Persson; S Berg; L Bevanger; K Bergh; R Valsö-Lyng; B Trollfors
Journal:  Clin Microbiol Infect       Date:  2007-11-22       Impact factor: 8.067

6.  Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.

Authors:  Christina R Phares; Ruth Lynfield; Monica M Farley; Janet Mohle-Boetani; Lee H Harrison; Susan Petit; Allen S Craig; William Schaffner; Shelley M Zansky; Ken Gershman; Karen R Stefonek; Bernadette A Albanese; Elizabeth R Zell; Anne Schuchat; Stephanie J Schrag
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

7.  Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups.

Authors:  Z Zhao; F Kong; X Zeng; H F Gidding; J Morgan; G L Gilbert
Journal:  Clin Microbiol Infect       Date:  2008-01-07       Impact factor: 8.067

Review 8.  Group B streptococcal conjugate vaccine: a timely concept for which the time has come.

Authors:  Morven S Edwards
Journal:  Hum Vaccin       Date:  2008-11-26

9.  Invasive group B streptococcal infections in infants, France.

Authors:  Claire Poyart; Hélène Réglier-Poupet; Asmaa Tazi; Annick Billoët; Nicolas Dmytruk; Philippe Bidet; Edouard Bingen; Josette Raymond; Patrick Trieu-Cuot
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

10.  A confidence interval for the wallace coefficient of concordance and its application to microbial typing methods.

Authors:  Francisco R Pinto; José Melo-Cristino; Mário Ramirez
Journal:  PLoS One       Date:  2008-11-11       Impact factor: 3.240

View more
  25 in total

1.  Clinical and microbiological features associated with group B Streptococcus bone and joint infections, France 2004-2014.

Authors:  S Kernéis; C Plainvert; J-P Barnier; A Tazi; N Dmytruk; B Gislain; J Loubinoux; F El Sayed; V Cattoir; N Desplaces; V Vernet; P Morand; C Poyart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-26       Impact factor: 3.267

2.  High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.

Authors:  Hui Wang; Chunjiang Zhao; Wenqiang He; Feifei Zhang; Liyan Zhang; Bin Cao; Ziyong Sun; Yingchun Xu; Qing Yang; Yaning Mei; Bijie Hu; Yunzhuo Chu; Kang Liao; Yunsong Yu; Zhidong Hu; Yuxing Ni
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

3.  Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility.

Authors:  Noriyuki Nagano; Yukiko Nagano; Masami Toyama; Kouji Kimura; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

4.  Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.

Authors:  Sarah Teatero; Allison McGeer; Donald E Low; Aimin Li; Walter Demczuk; Irene Martin; Nahuel Fittipaldi
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

5.  Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

Authors:  Mary Meehan; Robert Cunney; Mary Cafferkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-28       Impact factor: 3.267

6.  Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013.

Authors:  Areej Alhhazmi; Donna Hurteau; Gregory J Tyrrell
Journal:  J Clin Microbiol       Date:  2016-04-20       Impact factor: 5.948

7.  Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.

Authors:  A Bergal; L Loucif; D E Benouareth; A A Bentorki; C Abat; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-28       Impact factor: 3.267

8.  Distribution of pilus islands in Streptococcus agalactiae that cause human infections: insights into evolution and implication for vaccine development.

Authors:  E R Martins; A Andreu; J Melo-Cristino; M Ramirez
Journal:  Clin Vaccine Immunol       Date:  2012-12-26

9.  The incidence of inflammation among patients suffering from cervix cancer with positive beta haemolytic streptococci cultures from genital tract.

Authors:  Zefiryn Cybulski; Bartosz Urbański; Alicja Grabiec; Zofia Talaga; Michał Pawlak; Żaneta Wareńczak-Florczak; Andrzej Roszak
Journal:  Rep Pract Oncol Radiother       Date:  2019-09-11

10.  A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice.

Authors:  Joana Alves; Pedro Madureira; Maria Teresa Baltazar; Leandro Barros; Liliana Oliveira; Ricardo Jorge Dinis-Oliveira; Elva Bonifácio Andrade; Adília Ribeiro; Luís Mira Vieira; Patrick Trieu-Cuot; José Alberto Duarte; Félix Carvalho; Paula Ferreira
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.